BioSig Technologies, Inc. (BSGM)
USD 0.49
(-2.65%)
USD 0.49
(-2.65%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 103 Thousand USD | -77.21% |
| 2022 | 452 Thousand USD | 21.18% |
| 2021 | 373 Thousand USD | 37200.0% |
| 2020 | 1000.00 USD | -99.68% |
| 2019 | 311.13 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 831.81 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 500 Thousand USD | 385.44% |
| 2024 Q2 | 15 Thousand USD | -100.0% |
| 2023 Q3 | 193 Thousand USD | -31.56% |
| 2023 Q4 | 103 Thousand USD | -46.63% |
| 2023 FY | 103 Thousand USD | -77.21% |
| 2023 Q1 | 368 Thousand USD | -18.58% |
| 2023 Q2 | 282 Thousand USD | -23.37% |
| 2022 Q3 | 536 Thousand USD | -11.99% |
| 2022 Q4 | 452 Thousand USD | -15.67% |
| 2022 Q1 | 318 Thousand USD | -14.75% |
| 2022 FY | 452 Thousand USD | 21.18% |
| 2022 Q2 | 609 Thousand USD | 91.51% |
| 2021 FY | 373 Thousand USD | 37200.0% |
| 2021 Q3 | 409 Thousand USD | 40800.0% |
| 2021 Q4 | 373 Thousand USD | -8.8% |
| 2021 Q1 | 28 Thousand USD | 2700.0% |
| 2021 Q2 | 1000.00 USD | -96.43% |
| 2020 FY | 1000.00 USD | -99.68% |
| 2020 Q1 | 201.32 Thousand USD | -35.29% |
| 2020 Q2 | 88.57 Thousand USD | -56.0% |
| 2020 Q3 | 22.36 Thousand USD | -74.75% |
| 2020 Q4 | 1000.00 USD | -95.53% |
| 2019 Q2 | 468.27 Thousand USD | 106.71% |
| 2019 FY | 311.13 Thousand USD | 0.0% |
| 2019 Q1 | 226.53 Thousand USD | 0.0% |
| 2019 Q3 | 375.16 Thousand USD | -19.88% |
| 2019 Q4 | 311.13 Thousand USD | -17.07% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q3 | 218 Thousand USD | -88.27% |
| 2013 Q1 | 218 Thousand USD | -73.79% |
| 2013 Q2 | 1.85 Million USD | 752.59% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | - USD | -100.0% |
| 2012 Q4 | 831.81 Thousand USD | 0.0% |
| 2012 FY | 831.81 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 99.715% |
| BrainsWay Ltd. | 239 Thousand USD | 56.904% |
| Cerus Corporation | 59.79 Million USD | 99.828% |
| Envoy Medical, Inc. | 404 Thousand USD | 74.505% |
| electroCore, Inc. | 537 Thousand USD | 80.819% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -758.333% |
| IceCure Medical Ltd | 376 Thousand USD | 72.606% |
| Inogen, Inc. | 18.27 Million USD | 99.436% |
| OrthoPediatrics Corp. | 13.45 Million USD | 99.235% |
| Lucid Diagnostics Inc. | 199 Thousand USD | 48.241% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | 71.682% |
| MaxCyte, Inc. | 17.96 Million USD | 99.427% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -86.311% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.889% |
| PAVmed Inc | 2.96 Million USD | 96.52% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 98.342% |
| RxSight, Inc. | 1.21 Million USD | 91.495% |
| Sight Sciences, Inc. | 31.7 Million USD | 99.675% |
| SI-BONE, Inc. | 36.06 Million USD | 99.714% |
| TELA Bio, Inc. | 40.51 Million USD | 99.746% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.806% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 93.228% |
| Acutus Medical, Inc. | 32.65 Million USD | 99.685% |
| Talis Biomedical Corporation | 16.78 Million USD | 99.386% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 97.454% |
| CVRx, Inc. | 30.38 Million USD | 99.661% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 89.871% |
| Bioventus Inc. | 366.99 Million USD | 99.972% |
| Venus Concept Inc. | 70.79 Million USD | 99.854% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 91.72% |
| LivaNova PLC | 568.54 Million USD | 99.982% |
| 908 Devices Inc. | 3.92 Million USD | 97.378% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.98% |
| Nemaura Medical Inc. | 3.08 Million USD | 96.664% |
| NeuroPace, Inc. | 56.95 Million USD | 99.819% |
| LENSAR, Inc. | 1.75 Million USD | 94.114% |
| Apyx Medical Corporation | 33.18 Million USD | 99.69% |
| Cutera, Inc. | 418.69 Million USD | 99.975% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 99.315% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 99.617% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 98.965% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.993% |
| Axonics, Inc. | 25.84 Million USD | 99.601% |
| Outset Medical, Inc. | 134.59 Million USD | 99.923% |
| IRIDEX Corporation | 1.75 Million USD | 94.118% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.799% |
| IRadimed Corporation | 1.61 Million USD | 93.623% |
| Tivic Health Systems, Inc. | 176 Thousand USD | 41.477% |
| INVO Bioscience, Inc. | 6.77 Million USD | 98.48% |
| Telesis Bio, Inc. | 5.26 Million USD | 98.045% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 98.275% |
| Varex Imaging Corporation | 464.2 Million USD | 99.978% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.831% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 82.483% |
| Pulmonx Corporation | 35.08 Million USD | 99.706% |
| Dynatronics Corporation | 3.25 Million USD | 96.839% |
| Modular Medical, Inc. | 817 Thousand USD | 87.393% |
| ReShape Lifesciences Inc. | 151 Thousand USD | 31.788% |
| Semler Scientific, Inc. | 70 Thousand USD | -47.143% |
| InMode Ltd. | 6.61 Million USD | 98.442% |
| Bruker Corporation | 1.14 Billion USD | 99.991% |
| Cytosorbents Corporation | 2.54 Million USD | 95.949% |
| DexCom, Inc. | 2.57 Billion USD | 99.996% |
| Align Technology, Inc. | 96.96 Million USD | 99.894% |
| Viveve Medical, Inc. | 5.12 Million USD | 97.99% |
| ZimVie Inc. | 508.79 Million USD | 99.98% |
| Movano Inc. | 15.00 USD | -686566.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 99.432% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.974% |
| Profound Medical Corp. | 4.97 Million USD | 97.929% |
| Insulet Corporation | 1.36 Billion USD | 99.992% |
| enVVeno Medical Corporation | 1.06 Million USD | 90.32% |
| Surmodics, Inc. | 29.4 Million USD | 99.65% |
| iCAD, Inc. | 273 Thousand USD | 62.271% |
| Nuwellis, Inc. | 221 Thousand USD | 53.394% |
| Biotricity, Inc. | 10.85 Million USD | 99.051% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 99.705% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 84.148% |
| InspireMD, Inc. | 1.03 Million USD | 90.077% |
| PAVmed Inc. | 2.96 Million USD | 96.52% |
| BIOLASE, Inc. | 13.98 Million USD | 99.263% |
| Beyond Air, Inc. | 14.72 Million USD | 99.3% |
| FONAR Corporation | 37.92 Million USD | 99.728% |
| AxoGen, Inc. | 46.6 Million USD | 99.779% |
| Vivani Medical, Inc. | 19.31 Million USD | 99.467% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 99.769% |
| Inari Medical, Inc. | 30.35 Million USD | 99.661% |
| UFP Technologies, Inc. | 28 Million USD | 99.632% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | 76.27% |
| Tenon Medical, Inc. | 428 Thousand USD | 75.935% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 89.721% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 95.214% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.995% |
| Sintx Technologies, Inc. | 3.68 Million USD | 97.206% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 99.723% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 82.483% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 82.718% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.988% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.98% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 83.031% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -11.369% |
| Hyperfine, Inc. | 64 Thousand USD | -60.938% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.945% |
| Biomerica, Inc. | 459 Thousand USD | 77.56% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 77.085% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | 45.786% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.864% |